CTICasesTKI-Induced Pneumonitis
Imaging findings
Extensive, confluent, ground-glass opacity with a small pleural effusion. The findings were reversible upon cessation of the tyrosine kinase inhibitor.
Key takeaways
Certain tyrosine kinase inhibitors can cause pulmonary toxicity manifesting as pneumonitis, which is typically reversible once the offending drug is discontinued.
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Disseminated BlastomycosisInfection
- Daptomycin-Induced Lung ToxicityILD
- Pulmonary VarixVascular
- Sjogren's Syndrome with Cystic Lung DiseaseAutoimmune
- Nodular AmyloidosisMetabolic
- Lemierre's Syndrome MimicInfection
- Migrated IVC FilterIatrogenic
- Migrated Intrauterine Device (IUD)Iatrogenic
See all cases from October 21, 2016 →
Related ILD cases
- Lymphocytic Interstitial Pneumonia (LIP) in IgA Deficiency
- Short Telomere Syndrome with UIP Pattern, Cirrhosis, Splenomegaly, and Hepatopulmonary Syndrome
- Dyskeratosis Congenita with Upper-Lobe Predominant UIP
- COPA Syndrome (Genetic Interstitial Lung Disease with Recurrent Pulmonary Hemorrhage and Arthritis)
- Pleuroparenchymal Fibroelastosis (PPFE)
- Amiodarone Toxicity